We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

5 hedge funds and large institutions have $22K invested in PDL BioPharma, Inc. in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
1
Amalgamated Financial
New York
$22K +$22K +8,806 New

PDLI Hedge Fund Activity: Q1 2022 in Review

5 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q1 2022, worth a combined $22K.

Fund positioning in PDLI was balanced in Q1 2022: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.

  • 5 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $22K of PDL BioPharma, Inc. stock for Q1 2022.
  • 2 funds opened new PDL BioPharma, Inc. positions in Q1 2022 and 2 closed out, a net change of 0 holders.

Based on aggregated 13F filings for Q1 2022.